Doç. Dr. Semiha Urvay
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Carcinoma, Non-Small-Cell Lung 3 publicationsSource: OpenAlex / PubMed MeSHView publications
- Lung Neoplasms 3 publications
- Stomach Neoplasms 3 publications
- Neoplasms 3 publications
- Prostatic Neoplasms 2 publications
- Adenocarcinoma 2 publications
- Colonic Neoplasms 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.
- Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
- Baş Boyun Kanserleri
- Kolorektal Kanserler (Kolon ve Rektum Kanseri)
- Meme Kanseri
- Mide Kanseri
- Pankreas Kanseri
- Jinekolojik Tümörler ve Kanserler (Rahim, Serviks, Yumurtalık/Over Kanseri vb.)
- Yumurtalık (Over) Kanseri
- Akciğer Kanseri
- Kolon (Kalın Bağırsak) Kanseri
CV
Education and experience
Experience
- 2016Acıbadem Sağlık Grubuacibadem.com.tr
- 2015 - 2016Cumhuriyet Üniversitesi Tıp Fakültesi / Yardımcı Doçentacibadem.com.tr
- 2013 - 2015Sivas Numune Hastanesi / Mecburi Hizmetacibadem.com.tr
- 2009Çankırı Devlet Hastanesi / Mecburi Hizmetacibadem.com.tr
- 2003 - 2008Ankara Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı / İç Hastalıkları Araştırma Görevlisiacibadem.com.tr
Education
- 2013Ankara Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
- 2008Ankara Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
- 2003İstanbul Üniversitesi İstanbul Tıp Fakültesi, Üniversiteacibadem.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologyacibadem.com.trFrom source
- InstitutionAcıbadem Kayseri Hastanesiacibadem.com.trFrom source
- Area of workCarcinoma, Non-Small-Cell LungExtracted from 3 publications · Model version —From source
- Publications33 publicationsOpenAlexFrom source
- Last synchronised4 November 2026 21:04https://www.acibadem.com.tr/doktor/semiha-urvay/acibadem.com.tr
Scientific work
Publications on Carcinoma, Non-Small-Cell Lung
-
Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy
Biomarkers, 2026
DOI 10.1080/1354750x.2026.2621291 PMID 41579336 1 citation (Europe PMC) Source: OpenAlex
-
Assessing Early Treatment Response in mCSPC using KELIM PSA Score: Implications for Survival
Urologia Internationalis, 2026
DOI 10.1159/uin/aewag017 PMID 42671968 Source: OpenAlex
-
Bone Metastasis Distribution Matters: Prognostic Effect of the Axial‐to‐Peripheral Ratio in Metastatic Hormone‐Sensitive Prostate Cancer
The Prostate, 2026
DOI 10.1002/pros.70176 PMID 41950364 Source: OpenAlex
-
Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions
Medicina, 2026
DOI 10.3390/medicina62050987 PMID 42195240 Open-access full textSource: OpenAlex
-
Palliative Care Awareness Among Caregivers of Cancer Patients in Turkey: A Cross-Sectional Study
Current Oncology, 2026
DOI 10.3390/curroncol33080458 PMID 42645362 Open-access full textSource: OpenAlex
-
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Scientific Reports, 2025
DOI 10.1038/s41598-025-96157-6 PMID 40188172 8 citations (Europe PMC) Open-access full textSource: OpenAlex
-
HEREDITARY COLORECTAL CANCER SYNDROMES
Turkiye Klinikleri eBooks, 2025
DOI 10.5336/978-625-395-770-4_p17 Source: OpenAlex
-
Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks?
European Journal of Clinical Pharmacology, 2025
DOI 10.1007/s00228-025-03810-0 PMID 39971806 1 citation (Europe PMC) Source: OpenAlex
-
Prognostic Effect of KELIM Score of Prostate‐Specific Antigen in Hormone‐Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways
The Prostate, 2025
DOI 10.1002/pros.70098 PMID 41277135 Source: OpenAlex
-
A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy
Medicine, 2024
DOI 10.1097/md.0000000000037972 PMID 38787994 2 citations (Europe PMC) Open-access full textSource: OpenAlex